Intelligence IAMay 4, 2026Primary Market
Article
EnteroBiotix · £19M · Series Unknown
EnteroBiotix has secured £19 million in funding to support a clinical trial for microbiome-based therapies targeting irritable bowel syndrome. The company is based in Glasgow.
Généré par IA : résumés rédigés par une IA à partir des sources citées. Notre usage de l'IA
Généré par IASource: Unknown
01
Brief source
EnteroBiotix has secured £19 million in funding to support a clinical trial for microbiome-based therapies targeting irritable bowel syndrome. The company is based in Glasgow.